Astoria Portfolio Advisors Llc. Astrazeneca PLC Transaction History
Astoria Portfolio Advisors Llc.
- $240 Million
- Q4 2024
A detailed history of Astoria Portfolio Advisors Llc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Astoria Portfolio Advisors Llc. holds 4,372 shares of AZN stock, worth $314,740. This represents 0.12% of its overall portfolio holdings.
Number of Shares
4,372
Previous 4,372
-0.0%
Holding current value
$314,740
Previous $340,000
15.88%
% of portfolio
0.12%
Previous 0.12%
Shares
10 transactions
Others Institutions Holding AZN
# of Institutions
1,350Shares Held
477MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.53 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$3.02 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.68 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.65 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.38 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $223B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...